A Study of 3 Biotechs – a Story of Hope, Potential and Partnerships

A Study Of 3 Biotechs – A Story Of Hope, Potential And Partnerships
Athersys has a trial for MultiStem for use in patients suffering from ischemic stroke and also a trail going with Pfizer (PFE) for patients suffering from ulcerative colitis. Both are in Stage II clinical studies. Athersys has also submitted plans to … Read more on Seeking Alpha

The Stem Cell Revolution Can Jump-Start Your Portfolio: Jason Kolbert
In addition to heart disease, Mesoblast is pursuing degenerative disc disease (DDD) and spinal fusion, both local indications, and systemically, type 2 diabetes and rheumatoid arthritis, all with its mesenchymal precursor cells (MPCs). Athersys is … Read more on Trefis

Health care researchers aim to harness signals
“The real dream for the research, at least for people with brain stem stroke or cervical spinal cord injury, would be to one day reconnect brain to limb, take these signals out of the brain and root them back down to stimulating electrodes elsewhere in … Read more on The Augusta Chronicle